Delivery Order SPE2DB22D1002-SPE2DB25FLHT0
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $31,152.11 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes with a completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $91,492.20 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 13, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,837.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed-price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a prescription biologic medication used to treat various inflammatory conditions, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $8,674.31. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions, and this delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,860.78 for Dupixent 300 mg/2 ml syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which is not set-aside, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other inflammatory conditions, making...
- The Defense Logistics Agency awarded a delivery order valued at $17,795.66 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions, and...
- The Defense Logistics Agency awarded a $79,236.52 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on September 4, 2025, with completion targeted for September 5, 2025. This competitive, firm fixed-price award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions, including asthma, atopic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a contract value of $42,767.05. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,062.24 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $6,837.84. This delivery order represents a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 1, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication...